Core Viewpoint - Luxshare Precision's IPO in Hong Kong aims to enhance its global strategy, improve overseas financing capabilities, and increase governance transparency [3][11]. Group 1: Company Overview - Luxshare Precision, founded in 2004 and listed on the Shenzhen Stock Exchange in 2010, has become a leading player in the consumer electronics supply chain, particularly known for manufacturing components for Apple products [5][15]. - As of July 4, 2025, Luxshare's stock price was 33.92 CNY per share, with a total market capitalization of 246 billion CNY [5]. - The company operates across various sectors, including consumer electronics, communications, automotive, and medical, producing a wide range of products from connectors to TWS earphones [5][7]. Group 2: Financial Performance - Luxshare's revenue and net profit have shown consistent growth from 2022 to 2024, with revenues of 214.03 billion CNY, 231.90 billion CNY, and 268.80 billion CNY, and net profits of 9.16 billion CNY, 10.95 billion CNY, and 13.37 billion CNY respectively [7][8]. - The consumer electronics segment remains the largest revenue source, contributing 83.37% of total revenue in 2024, although the company is diversifying its income streams [8][9]. Group 3: Market Position and Strategy - Luxshare's client base includes major global brands like Samsung and Huawei, and it has established manufacturing bases in multiple countries to support its global operations [9][11]. - The company plans to use the funds raised from the IPO to expand its overseas business, invest in new technology, and enhance its global production capacity [11][19]. - Luxshare has been actively pursuing diversification to reduce reliance on Apple, with strategic acquisitions and partnerships in the automotive sector, including a significant investment in Chery and the acquisition of Leoni AG [17][19]. Group 4: Leadership and Background - The founder, Wang Laichun, has a remarkable story, transitioning from a factory worker at Foxconn to leading a company with a market value of 246 billion CNY [20][26]. - Wang's leadership has been pivotal in Luxshare's growth, and she has been recognized as a leading figure in the business community, ranking first in influential businesswomen in China for three consecutive years [20][26].

证券代码：839273 证券简称：一致魔芋 公告编号：2025-082 湖北一致魔芋生物科技股份有限公司 投资者关系活动记录表 本公司及董事会全体成员保证公告内容的真实、准确和完整，没有虚假记载、 误导性陈述或者重大遗漏，并对其内容的真实性、准确性和完整性承担个别及连 带法律责任。 一、 投资者关系活动类别 √特定对象调研 □业绩说明会 □媒体采访 √现场参观 □新闻发布会 □分析师会议 □路演活动 √其他 投资者网络会议 二、 投资者关系活动情况 活动时间：2025 年 7 月 2 日至 2025 年 7 月 3 日 活动地点：公司会议室、腾讯网络会议 参会单位及人员：东吴证券、光大证券、贝寅基金、长江证券、招银理财、 恒安标准人寿、JP MORGAN、AEGON INDUSTRIAL FUND MANAGEMENT CO LTD、GOLDMAN SACHS ASSET MANAGEMENT 、 GREENWOODS ASSET MGMT LTD 、 MANULIFE ASSET MANAGEMENT、MILLENNIUM PARTNERS、NOMURA ASSET MANAGEMENT、OXBOW CAP ...

2025中国企业全球化新势力100强榜单重磅来袭，旨在揭晓那些引领行业、闪耀全球的先锋企业 。 本次评选主要采用调研回访+专家评委评审 （完整专家评委名单详见文末） 的模式。经过 对申报企 业进行数据核实、研究分析与调研评审，结合企业的运营数据、财务数据、本土化布局及全球市场影 响力等维度，最终评选出 "2025中国企业全球化新势力100强" 。 本次榜单分为 「引领型」 和 「成长型」 两个组别。 其中， 「引领型」企业有40家，2024年在海 外市场已实现不低于1000万美金的营收；「成长型」企业有60家，截至目前已在海外市场实现营 收，在全球化市场中具备高瞻远瞩的战略部署能力。 以下为本次榜单企业完整名单 ▼ 111 | 1乙三科 | | 方案提供商 | | --- | --- | --- | | 易来科得 | 新能源 | 为全球电池产业提供前沿软件和高 端技术服务 | | 易买工品 | 电商 | 世界级工业品一站式采购商城平台 | | 易思维 | 智能制造 | 引领机器视觉创新,加速智能工业 委車 | | 盈科视控 | 智能制造 | 泛半导体AI智慧工厂专家 | | 影伙引擎 | 人工智能 | Al驱 ...

证券代码：301029 证券简称：怡合达 东莞怡合达自动化股份有限公司 投资者关系活动记录表 编号：2025-004 投资者关系活 动类别 ☑特定对象调研 □分析师会议 □媒体采访 □业绩说明会 □新闻发布会 □路演活动 ☑现场参观 ☑其他（电话会议） 参与单位名称 详见附件《与会清单》 时间 2025 年 6 月 9 日-7 月 3 日 地点 线上：电话会议 线下：东莞市横沥镇村尾桃园二路 33 号、上海策略会、深圳策略 会等 上市公司接待 人员姓名 董事长、总经理：金立国 副总经理：黄强 董事会秘书：张美琪 投资者关系代表：范见涛 证券事务代表：廖芙雨、杨景凤 投资者关系活 动主要内容介 绍 本次调研活动主要问题及回答如下： Q1：近年竞争情况如何，友商是否有价格方面的动作？ A：客户在 FA 零部件选购中，采购决策要素众多，并非单单 考虑价格因素，比如：开发产品的先进性、产品选择的丰富度、 对客户场景的适配性、工程师设计选型的便捷度、交易过程的便 利性、交付的及时性、品质稳定性和可靠性、服务的及时性等众 多因素，加上价格才是购买决策综合要素。相比价格，交期、品 质一致性、服务、产品品类等因素对客户的购买 ...

Core Insights - The company reported a revenue of 36.726 billion yuan in 2024, reflecting a growth of 5.14%, with a net profit attributable to shareholders of 11.668 billion yuan, up by 0.74% [1] - In Q4 2024, the company experienced a revenue decline of 5.08% to 7.241 billion yuan, while net profit surged by 40.99% to 1.031 billion yuan [1] - The first quarter of 2025 saw a revenue drop of 12.12% to 8.237 billion yuan, with net profit decreasing by 16.81% to 2.629 billion yuan [1] Financial Performance - The overall gross margin for 2024 was 63.14%, a decrease of 1.08%, primarily due to changes in business structure and product pricing adjustments [2] - The company’s operating cash flow for 2024 was 12.432 billion yuan, an increase of 12.38% [1] - The gross margin for Q1 2025 improved by 6.57 percentage points to 62.53%, indicating that short-term adjustments may have been largely absorbed [2] Business Segments - The Life Information and Support segment generated 13.557 billion yuan in 2024, a decline of 11.11%, but the minimally invasive surgery business grew by over 30% [3] - The In Vitro Diagnostics segment achieved a revenue of 13.765 billion yuan, up by 10.82%, despite domestic challenges due to policy changes [3] - The Medical Imaging segment reported a revenue of 7.498 billion yuan, reflecting a growth of 6.60%, with high-end ultrasound models contributing significantly [3] International Expansion - The company’s international business grew by 21.28% in 2024, accounting for approximately 45% of total revenue, driven by high-end customer acquisition and local platform development [2] - The In Vitro Diagnostics international business saw over 30% growth, with local production projects initiated in 13 countries [3] Research and Development - The company maintained high R&D investment levels, with 4.008 billion yuan in 2024, representing 10.91% of revenue [4] - As of March 31, 2025, the company had applied for approximately 12,000 patents, with 5,973 patents granted [4] Shareholder Returns - The company distributed a total cash dividend of 7.602 billion yuan in 2024, with a cash dividend ratio of 65.15% [4] - A mid-term profit distribution plan for 2025 proposes a cash dividend of 1.710 billion yuan, reflecting strong profitability and commitment to shareholder returns [4]

Core Viewpoint - EVE Energy is pursuing a secondary IPO in Hong Kong to raise approximately 30 billion HKD for global expansion and production capacity enhancement, aiming to differentiate itself in a market dominated by CATL and BYD [2][5]. Group 1: IPO and Financing - EVE Energy plans to issue up to 10% of its total share capital in H-shares, with an option for an additional 15% in oversubscription [2]. - The company has previously raised 19 billion CNY through various financing methods since 2019, primarily for production expansion [5]. - The funds from the IPO will be allocated to projects in Hungary and Malaysia, which are crucial for its overseas production capacity [5][6]. Group 2: Business Segments and Market Position - EVE Energy operates in three main segments: consumer batteries, power batteries, and energy storage batteries, with power and storage batteries becoming the main revenue drivers [3][4]. - In 2024, EVE Energy's global market share in consumer batteries is projected to be 11.7%, ranking third, while its share in power batteries is only 2.8%, placing it fifth [3][4]. - The company has seen significant growth in its energy storage segment, achieving a market share of 17.2%, surpassing BYD to become the second-largest globally [4]. Group 3: Financial Performance and Challenges - EVE Energy's revenue for 2024 is expected to be 48.615 billion CNY, showing a slight decline, with net profit dropping by 6.61% to 4.221 billion CNY [4][6]. - The decline in revenue is primarily attributed to a 20% drop in power battery revenue, highlighting the competitive pressure from industry leaders [4][6]. - Despite high revenue growth in Q1 2025, the company's profit margins are under pressure, with a net profit increase of only 3.32% despite a 37.34% revenue growth [7].

国金证券主要观点如下： 东南亚为美国轮胎的主要进口地区，虽然存在关税风险但短期美国本土产能难以实现补充供应 美国自2014年开始陆续对我国乘用车和轻型货车轮胎、卡车和公共汽车轮胎、非公路轮胎发起双反调 查，国内轮胎企业通过出海建厂应对政策变化，距离较近且橡胶产能丰富的东南亚成为了首选。随着泰 国、越南等地新建轮胎产能逐渐落地，对美国的轮胎出口量也开始快速增长，2020年美国双反政策覆盖 面也扩大到了泰国和越南等地，尽管今年4月开始美国关税的阴影也笼罩了东南亚地区，但是考虑到原 料配套和成本优势东南亚依然是轮胎企业出海的首站。 智通财经APP获悉，国金证券发布研报称，7月2日晚间，特朗普表示已与越南达成贸易协议。根据协 议，越南所有出口至美国的商品将被征收20%的关税，而任何转运货物将被征收40%的关税。目前，美 国尚未公布适用40%关税的具体商品清单。目前，尚不清楚该协议是否已最终达成，或者越南是否同意 特朗普宣布的内容。考虑到全球各地未来贸易政策的变化有不确定性，实现海外多基地布局的企业经营 更具稳定性，并且随着未来海外基地产能顺利放量后将推动公司实现业绩增长和市占率提升。 根据隆众资讯数据，美国轮胎进口的 ...

2024年，在全球家具市场规模预计达7662亿美元的背景下，林氏木业海外品牌LINSY在新加坡开设首家 线下门店，这是该品牌去年在东南亚布局的第5家门店，标志着其全球化战略进入新阶段。此次布局不 仅完善了品牌O2O一体化布局，更展现了林氏木业深耕东南亚市场的决心。 新加坡门店选址核心商圈，延续了林氏木业因地制宜的店态特点。门店设计融合当地文化元素，贯 彻"时尚、舒适、多元"的品牌DNA，通过"所见即所得"的空间体验，为消费者打造沉浸式购物环境。产 品方面则发挥"全风格、全场景、全品类"优势，提供客餐卧一体的套系产品，满足多样化需求。经常有 人问"林氏木业家具怎么样"，值得注意的是，这个问题，在新加坡市场已经得到了初步验证——其产品 通过当地经销商渠道线上销售三年，已收获良好市场反馈。 【LINSY菲律宾店】 支撑林氏木业快速扩张的核心是其强大的产品力。品牌坚持"住进每一种偏爱"的理念，针对年轻消费群 体推出如包包椅等创新产品。这款融合时尚与功能的产品，完美诠释了林氏木业对消费者需求的精准把 握。同时，林氏木业依托270多家优质供应商构建的供应链网络，实现了每月上新超过200SKU，产品上 线最快30天完成的敏 ...

中国上市公司网/文 2025年7月4日，中国速冻食品行业的领军企业安井食品(603345.SH/02648.HK)成功在香港联合交易所挂 牌上市，成为继多家企业之后，又一实现"A+H"双资本平台布局的消费巨头。公司此次全球发行 3999.47万股H股，其中香港公开发售占比30%，国际发售占比70%。最终确定的发售价为每股60港元， 全球发售共募集资金净额达23.02亿港元。值得注意的是，香港公开发售部分获得44.2倍的超额认购，国 际发售部分亦获得5.85倍的超额认购，充分彰显了资本市场对安井食品长期价值的坚定认可。 作为国内首家成功实现"A+H"股双重上市的速冻食品企业，安井食品的港股上市不仅标志着其在全球化 战略上迈出了关键一步，更凸显了中国消费品牌在全球资本市场中的强大吸引力和广阔前景。 速冻食品赛道领军者，全产业链布局构筑壁垒 安井食品集团股份有限公司成立于2001年12月，总部位于福建，主营业务涵盖速冻调制食品、速冻菜肴 制品及速冻面米制品的研发、生产与销售。经过二十余年发展，公司已构建起覆盖全国的产销研网络， 在厦门、无锡、泰州、辽宁、四川、湖北、河南、广东、山东等地设有12大生产基地，并通过新宏 ...

2025 年 7 月 4 日星期五 地址： 电话： 重庆市江北区金沙门路 32 号 23 层； 023-67070250 1 市场有风险 投资需谨慎 上海市浦东新区世纪大道 210 号 10 楼 1001； 021-50591197 | | | | 铜： | | 16 | | --- | --- | --- | | 锡： | | 17 | | 镍： | | 17 | | 豆油、豆粕： | | 17 | | 棕榈油： | | 18 | | 菜粕、菜油： | | 19 | | 棉花： | | 19 | | 白糖： | | 20 | | 苹果： | | 21 | | 生猪： | | 21 | | 鸡蛋： | | 22 | | 玉米&淀粉： | | 23 | | 原木： | | 24 | | 免责声明 | | 25 | 国债： 上一交易日，国债期货收盘多数上涨，30 年期主力合约跌 0.02%报 121.130 元， 10 年期主力合约持平于 109.105 元，5 年期主力合约涨 0.01%报 106.255 元，2 年期主 力合约涨 0.01%报 102.514 元。 公开市场方面，央行公告称，7 月 3 日以固 ...